John Hawley

Joint ASCI/AAP Statement on American Health and the Biomedical Research Enterprise

Posted on by John Hawley

At this time of uncertainty across the U.S. biomedical and public health enterprise, the American Society for Clinical Investigation (ASCI) and the Association of American Physicians (AAP) stand with our members and physician-scientists of all career stages, including early stage investigators who are building their careers. We continue to track current events and we are working with colleagues across all States and partner organizations to understand the challenges we face – and to propose solutions.

All of us share in the joy of scientific discovery, the excitement of mentoring the newest generation of physician-scientists, and advancing our shared mission to improve the health of all Americans. As such, our work aligns well with our nation’s founding principle: “e pluribus unum.” Out of many, one.

In this spirit, we call on everyone to work with urgency toward securing and sustaining our workforce, with special consideration for the emerging generations of physician-scientists. This is the only way we can continue to fuel our country’s unparalleled innovation engine, our economic prosperity, and our health in the decades ahead. It is up to us, all of us.

With respect and gratitude,

— The Councils of the ASCI and the AAP

Call for submissions: ASCI member host labs, 2025–2027

Posted on by John Hawley

As part of the ASCI’s Postbac Program, the ASCI is pleased to call for submissions from Society members who are interested in their labs serving as hosts for Program finalists for 2025–2027.

Any member can provide a submission by:

The deadline for submissions is March 3, 2025, 11:59 pm Eastern.

Submissions consist of the following sections:

  • Your information
    • Your institution
    • Your trainee table (PDF upload)
  • About your lab
    • Lab website
    • Lab description and environment (500-word limit). Provide detail on mentoring awards, motivation for applying, and mentorship plan (what presentation will be expected, feedback provided, and participation).
    • Lab member who would be assigned for day-to-day mentoring of the postbac (name, position)
    • Assignee’s biosketch (PDF upload)
  • Institutional resources
    • Provide detail on aspects such as the requisite amount of bench/desk space in lab, faculty member to work with the student on medical-school essay, institutional career development, and educational and networking opportunities.
    • Institutional stipend levels. The ASCI expects stipends to fall within the ranges of the NIH post-bac IRTA program, with the understanding that the cost of living ranges widely depending on location. Provide information for 2025–2026 and 2026–2027.
    • Indicate if you are able to supplement beyond your institution’s stipend amounts or beyond the ASCI’s maximum grant of $55,000 ($50,000 direct; $5,000 indirect).

Nominations for ASCI Council, 2025

Posted on by John Hawley

  • Access your member account
  • Go to the “Nominations” tab
  • In the section for “Council vacancies”:
    • If you are the nominee, select the “I’m the nominee” option to start your part of the nomination (only you have access to this information).
    • If you are the nominator, select “I’m the nominator” option, then search for your nominee. Only nominees who are within the age-eligibility criteria will be returned in the results.

    The Society seeks nominations for the following ASCI Council vacancies arising in 2025 (all terms begin and end in the spring):

    • Vice President (4-year term, 2025-2029)
    • Councilor (2 positions, 3-year term, 2025-2028)

    Those eligible for nomination must be in the Active category and:

    • for Vice President, do not turn 56 until 2030 or later
    • for Councilor, do not turn 56 until 2029 or later

    The Society strongly encourages members to consider diversity in identifying those suitable for nomination. Self-nominations are not permitted. Nominations may be submitted by any member in good standing (with dues up to date if applicable) and must be submitted by February 17, 2025, at 11:59 PM EST.

    All Council members are expected to support the activities of and attend the ASCI annual meeting, and to participate in the general governance of the Society, including two in-person meetings (fall and spring, with the spring meeting occurring as part of the annual meeting) and videoconference calls (typically every other month). All Council members participate in the review of membership and various award nominations and subsequent discussion at the fall meeting.

    The Vice President transitions to President-Elect in year 2, President in year 3, and Immediate Past President in year 4. For the 2nd through 4th years of this position, this member is expected to participate significantly in matters related to the annual meeting. In the Presidential year (year 3), the member convenes a face-to-face Council meeting and oversees related review processes for nominations, notably including those to membership. The President works closely with the Association of American Physicians to create the annual meeting program and presents the traditional Presidential Address at the meeting.

    The Council is supported by an Executive Director, Managing Director, and other staff members who oversee the day-to-day operations of the Society and effect initiatives as directed by the Council. For details on Officers and Councilors, see the ASCI Bylaws.

    Nominators:

    • may be any ASCI member
    • must provide a statement (250-word limit) regarding the nominee

    Nominees:

    • must specify the position of interest (Vice President, Councilor);
    • provide a 250-word candidate statement, written in first person, for consideration by the Council and for use as the ballot statement if the nominee is selected as a candidate (nominees may refer to candidate statements for the 2024 nomination cycle for guidance in drafting their own statements);
    • provide an NIH-style biosketch;
    • must complete the ASCI’s demographic survey and provide information about research domain(s).

    To start a nomination:

    • Access your member account
    • Go to the “Nominations” tab
    • In the section for “Council vacancies”:
      • If you are the nominee, select the “I’m the nominee” option to start your part of the nomination (only you have access to this information).
      • If you are the nominator, select “I’m the nominator” option, then search for your nominee. Only nominees who are within the age-eligibility criteria will be returned in the results.

    The ASCI’s 2025 Active and International elected members

    Posted on by John Hawley

    The ASCI is pleased to announce the election of 99 Active and International members for 2025.

    These new members come from 46 different institutions and represent excellence across the breadth of academic medicine. They will be officially inducted into the Society at the ASCI Dinner and New Member Induction Ceremony, April 25, 2025, as part of the AAP/ASCI/APSA Joint Meeting, April 25–27, at the Swissotel Chicago.

    Active and International members, 2025

    Daniel Addison, MD
    Ohio State University College of Medicine
    Sally Nneoma Sarah Adebamowo, MBBS, MSc, ScD
    University of Maryland School of Medicine
    Manmeet Singh Ahluwalia, MD, MBA
    Florida International University
    Niroshana Anandasabapathy, MD, PhD
    Weill Cornell Medicine
    Jason Randolph Andrews, MD
    Stanford University School of Medicine
    Saro H. Armenian, DO, MPH
    City of Hope Medical Center
    Pratiti Bandopadhayay, MBBS, PhD
    Harvard Medical School, Dana-Farber Cancer Institute
    Alexander G. Bick, MD, PhD
    Vanderbilt University Medical Center
    Ranjit S. Bindra, MD, PhD
    Yale School of Medicine
    Eli A. Boritz, MD, PhD
    NIH, National Institute of Allergy and Infectious Diseases (NIAID)
    David A. Braun, MD, PhD
    Yale School of Medicine
    Joshua D. Brody, MD
    Icahn School of Medicine at Mount Sinai
    Cesar Martin Castro, MD, MS, MMSc
    Harvard Medical School, Massachusetts General Hospital
    Andrea Cercek, MD
    Memorial Sloan Kettering Cancer Center
    Rohit Chandwani, MD, PhD
    Weill Cornell Medicine
    Daniel I-Hsin Chu, MD, MSPH, FACS, FASCRS
    University of Alabama at Birmingham School of Medicine
    Nicole G. Coufal, MD, PhD
    University of California, San Diego, School of Medicine
    Mucio Kit Delgado, MD, MS
    University of Pennsylvania Perelman School of Medicine
    Rajat Deo, MD, MTR
    University of Pennsylvania Perelman School of Medicine
    Jörg Hans Wilhelm Distler, MD
    Heinrich-Heine-University Duesseldorf
    Michael Thomas Eadon, MD
    Indiana University School of Medicine
    Yi Fan, MD, PhD
    University of Pennsylvania Perelman School of Medicine
    Mariella G. Filbin, MD, PhD
    Harvard Medical School, Dana-Farber Cancer Institute
    Terence Peter Gade, MD, PhD
    University of Pennsylvania Perelman School of Medicine
    Ethan M. Goldberg, MD, PhD
    Children’s Hospital of Philadelphia
    Misty Good, MD, MS
    University of North Carolina School of Medicine
    Madhusudan Grover, MBBS
    Mayo Clinic
    Rajat M. Gupta, MD
    Harvard Medical School, Brigham & Women’s Hospital
    Lida P. Hariri, MD, PhD
    Harvard Medical School, Massachusetts General Hospital
    Takashi Hato, MD
    Indiana University School of Medicine
    Jorge Henao-Mejia, MD, PhD
    University of Pennsylvania Perelman School of Medicine
    Angela Christine Hirbe, MD, PhD
    Washington University School of Medicine in St. Louis
    Lori Rachel Holtz, MD, MSPH
    Washington University School of Medicine in St. Louis
    William Tzu-lung Hu, MD, PhD, FAAN
    Rutgers, Robert Wood Johnson Medical School
    Alison Ju-Tsu Huang, MD, MAS
    University of California, San Francisco, School of Medicine
    Jason T. Huse, MD, PhD
    University of Texas MD Anderson Cancer Center
    Tamara Isakova, MD, MMSc
    Northwestern University Feinberg School of Medicine
    Prasanna Jagannathan, MD
    Stanford University School of Medicine
    Tobias Janowitz, MBBChir, PhD
    Cold Spring Harbor Laboratory
    Robert R. Jenq, MD
    City of Hope Medical Center
    Wen Jiang, MD, PhD
    University of Texas MD Anderson Cancer Center
    Sadiya Sana Khan, MD, MSc
    Northwestern University Feinberg School of Medicine
    John B. Kisiel, MD, MS
    Mayo Clinic
    Jeffery M. Klco, MD, PhD
    St. Jude Children’s Research Hospital
    Liza (Yelizaveta) Konnikova, MD, PhD
    Yale School of Medicine
    Jonathan Andrew Kropski, MD
    Vanderbilt University School of Medicine
    Hrishikesh S. Kulkarni, MD, MSCI
    University of California, Los Angeles, David Geffen School of Medicine
    Sonia S. Kupfer, MD
    University of Chicago Pritzker School of Medicine
    Angelle Desiree LaBeaud, MD, MS
    Stanford University School of Medicine
    Anne C.C. Lee, MD, MPH
    Brown University Medical School
    Katherine Phoenix Liao, MD, MPH
    Harvard Medical School, Brigham & Women’s Hospital
    Robbie G. Majzner, MD
    Harvard Medical School, Dana-Farber Cancer Institute
    Rajeev Malhotra, MD, MA
    Harvard Medical School, Massachusetts General Hospital
    Joseph D. Mancias, MD, PhD
    Harvard Medical School, Dana-Farber Cancer Institute
    Nilam S. Mangalmurti, MD
    University of Pennsylvania Perelman School of Medicine
    Folasade P. May, MD, PhD, MPhil
    University of California, Los Angeles, David Geffen School of Medicine
    Megan E. McNerney, MD, PhD
    University of Chicago Pritzker School of Medicine
    Jaimie P. Meyer, MD, MS, FACP
    Yale School of Medicine
    Derek P. Narendra, MD, PhD
    National Institutes of Health
    Brian Timothy O’Neill, MD, PhD
    University of Iowa Carver College of Medicine
    Stephen T. Oh, MD, PhD
    Washington University School of Medicine in St. Louis
    Opeyemi A. Olabisi, MD, PhD
    Duke University School of Medicine
    Matthew G. Oser, MD, PHD
    Harvard Medical School, Dana-Farber Cancer Institute
    Eric Padron, MD
    Moffitt Cancer Center
    Akash Patnaik, MD, PhD, MMSc
    University of Chicago Pritzker School of Medicine
    Tien Peng, MD
    University of California, San Francisco, School of Medicine
    Paige M. Porrett, MD, PhD
    University of Alabama at Birmingham School of Medicine
    Camille E. Powe, MD
    Harvard Medical School, Massachusetts General Hospital
    David R. Raleigh, MD, PhD
    University of California, San Francisco, School of Medicine
    Deepak A. Rao, MD, PhD
    Harvard Medical School, Brigham & Women’s Hospital
    Meenakshi Rao, MD, PhD
    Harvard Medical School, Boston Children’s Hospital
    Abby Rachel Rosenberg, MD, MS, MA
    Harvard Medical School, Dana-Farber Cancer Institute
    Kathryn J. Ruddy, MD
    Mayo Clinic
    Elias Joseph Sayour, MD, PhD
    University of Florida College of Medicine
    Philip Oliver Scumpia, MD, PhD
    University of California, Los Angeles, David Geffen School of Medicine
    Chetan Seshadri, MD
    University of Washington School of Medicine
    Nilay Sethi, MD, PhD
    Harvard Medical School, Dana-Farber Cancer Institute
    Nirali N. Shah, MD, MHSc
    NIH, National Cancer Institute (NCI)
    Keith Magnus Sigel, MD, PhD, MPH
    Icahn School of Medicine at Mount Sinai
    Emily K. Sims, MD
    Indiana University School of Medicine
    Zirui Song, MD, PhD
    Harvard Medical School, Massachusetts General Hospital
    Tomokazu Souma, MD, PhD
    Duke University School of Medicine
    Kathryn Elaine Stephenson, MD, MPH
    Harvard Medical School, Beth Israel Deaconess Medical Center
    Sean Robinson Stowell, MD, PhD
    Harvard Medical School, Brigham & Women’s Hospital
    Paul C. Tang, MD, PhD
    Mayo Clinic
    Justin Taylor, MD
    University of Miami Miller School of Medicine
    Marmar Vaseghi, MS, MD, PhD
    University of California, Los Angeles, David Geffen School of Medicine
    Elizabeth C. Verna, MD, MSc, FAASLD, FAST
    Columbia University Vagelos College of Physicians and Surgeons
    Srinivas Raghavan Viswanathan, MD, PhD
    Harvard Medical School, Dana-Farber Cancer Institute
    Daniel R. Wahl, MD, PhD
    University of Michigan Medical School
    Amisha Wallia, MD, MS
    Northwestern University Feinberg School of Medicine
    Taia T. Wang, MD, PhD
    Stanford University School of Medicine
    Marc Nathan Wein, MD, PhD
    Harvard Medical School, Massachusetts General Hospital
    Craig Brian Wilen, MD, PhD
    Yale School of Medicine
    Michael Robert Wilson, MD, MAS
    University of California, San Francisco, School of Medicine
    Graeme F. Woodworth, MD
    University of Maryland School of Medicine
    Kelley Yan, MD, PhD
    Columbia University Vagelos College of Physicians and Surgeons
    Dmitriy Zamarin, MD, PhD
    Icahn School of Medicine at Mount Sinai
    Lilei Zhang, MD, PhD
    Baylor College of Medicine

    Please join us in congratulating these newly elected members!

    Nominations open for 2025 Honorary membership

    Posted on by John Hawley

    The ASCI is pleased to call for nominations for 2025 Honorary membership. Nominees for this recognition must fit the criteria as given in the ASCI bylaws:

    Any distinguished person who has contributed significantly to the Society’s objectives, who has not been previously and unsuccessfully nominated for Active or International membership, and who enjoys an unimpeachable moral standing is eligible for nomination in this category.

    For the nominee who meets these criteria, there is no restriction on age or degree held.

    The deadline for receipt of nominations is February 17, 2025, at 11:59 pm Eastern. Nominations will be screened to ensure they are complete and fit the nomination criteria. The Council reviews nominations and submits its recommendations to Active and Senior members for approval.

    The nominator must be an ASCI member in good standing and must start the nomination:

    • Access your member account
    • Go to the “Nominations” tab, then to the “Honorary membership nomination” section
    • Select “I’m the nominator” option
    • Search for your nominee:
      • If found, click on “Start nomination”
      • If no result is found, provide and save the requested information (first name, last name, and email address), then click on “Start nomination” for the newly created nominee in the “Results” section
    • At the top of the nomination form, click on “Send access notification to the nominee at: <email>”
    • Provide a 250-word limit statement on the nominee’s qualifications
    • Submit the statement, which can be done regardless of whether the nominee’s part of the nomination is completed

    The nominee receives an email with information to access their part of the nomination and then must:

    • Provide a birth date and address information
    • Provide a brief (300-word limit) biography
    • Provide current institutional affiliation
    • Upload a full curriculum vitae
    • Complete a demographics survey
    • Identify research domain(s)
    • Submit this aspect of the nomination, which can be done regardless of whether the nominator or supporter has completed their statement

    Announcing the ASCI PSSF Fellowship Program

    Posted on by John Hawley

    The American Society for Clinical Investigation (ASCI) is proud to announce its partnership with the Physician Scientist Support Foundation (PSSF), and the establishment of the ASCI PSSF Fellowship Program. 

    Recognizing the shared goal to bolster and sustain the pipeline of scholars entering the workforce, the ASCI has assumed the PSSF, positioning itself to expand innovative training pathways for emerging physician-scientists.

    The newly established ASCI PSSF Fellowship Program – formerly the PSSF Medical Student Research Fellowship (MSRF) – will continue to provide single-degree medical students with a one-year, rigorous training experience in biomedical research, guided by dedicated mentors. An eligible candidate must be a single-degree medical student interested in a dual career in research and patient care. They may not be enrolled in a combined degree program.

    The ASCI PSSF Fellowship includes:

    • A $42,000 stipend and an additional allowance of $8,000 for health insurance and travel expenses.
    • Complimentary registration and inclusive program access to the AAP/ASCI/APSA Joint Meeting.
    • 1:1 quarterly conversations with PSSF Advisory Committee mentors.
    • Access to ASCI’s virtual community programming including bi-monthly scientific seminars led by ASCI members and additional networking, enrichment, and career development activities.

    A key outcome of the merger was the establishment of the ASCI’s PSSF Advisory Committee, now comprising former PSSF’s founders and Board members. Guided by the ASCI Council, this group will remain dedicated to physician-scientist research as ambassadors of the ASCI PSSF Fellowship and mentors to its recipients. The Advisory Committee members are:

    For information or questions, please contact us at programs@the-asci.org.

    Nominations open for the 2025 Seldin~Smith Award for Pioneering Research

    Posted on by John Hawley

    The ASCI is pleased to call for nominations for the 2025 Seldin~Smith Award for Pioneering Research. The annual award, accompanied by an unrestricted $30,000 grant to advance academic efforts, honors an early-career physician-scientist who has demonstrated exceptional creativity and accomplishments in biomedical research (see past recipients).

    The deadline for receipt of nominations is Wednesday, November 13, at 11:59 pm Eastern.

    The nominee:

    • must be an MD (or the equivalent);
    • must be more than 2 years but not more than 6 years from first faculty (or the equivalent) appointment as of April 2025; and
    • spends substantial time in research while providing direct patient care.

    A nomination must be started by the nominator, who then notifies the nominee to complete her/his part of the nomination. The nominee identifies the supporter of the nomination and notifies that person through the submission site to complete her/his support form. Note: The nominee may not be a past recipient of the Foundation for the NIH’s Trailblazer Prize for Clinician-Scientists.

    Nominations will be screened to ensure they are complete and fit the nomination criteria. The Seldin~Smith Award Selection Committee reviews nominations and provides recommendations to the Seldin~Smith Award Advisory Committee to determine the recipient.

    The nominator must be an ASCI member in good standing and must start the nomination:

    • Access your member account
    • Go to the “Nominations” tab, then to the “ASCI / Seldin~Smith Award for Pioneering Research” section
    • Select “I’m the nominator” option
    • Search for your nominee:
      • If found, click on “Create nomination”
      • If no result is found, provide and save the requested information (first name, last name, and email address), then click on “Create nomination” for the newly created nominee in the “Results” section
    • At the top of the nomination form, click on “Send access notification to the nominee at: <email>”
    • Provide a 500-word limit statement on the nominee’s most significant achievement
    • Submit the statement, which can be done regardless of whether the nominee’s part of the nomination is completed

    The nominee receives an email with information to access her/his part of the nomination and then must:

    • Provide a birth date and address information
    • Provide a summary (100-word limit) of her/his research, followed by a notation of the percentage of time devoted to direct patient care
    • Provide detail of:
      • Degrees obtained
        • Year of first faculty or equivalent appointment
      • Current institutional affiliation
    • Upload:
      • Current NIH-style biosketch
      • Three significant publications, each with an annotation (100-word limit)
    • Identify the nomination’s supporter and send notification to the supporter to access her/his support form
    • Complete a demographics survey
    • Identify research domain(s)
    • Submit this aspect of the nomination, which can be done regardless of whether the nominator or supporter has completed her/his statement

    The supporter:

    • Does not need to be an ASCI member
    • Must be identified and notified by the nominee
    • Provides a statement (500-word limit) of the nominee’s research contributions (the statement should be distinct from that of the nominator)

    Nominations open for mid-career member awards, 2025

    Posted on by John Hawley

    The ASCI is pleased to call for nominations for awards recognizing the scholarly achievements of mid-career members:

    The Marian W. Ropes, MD, Award recognizes a middle-career woman physician-scientist. The annual award honors Dr. Ropes (1903–1994), a pioneer both as a researcher on the role of synovial fluid in joint diseases and as a woman in academic medicine. She was the first woman documented to have been elected to the ASCI. The recipient of this award will receive a $10,000 honorarium, be recognized at the ASCI’s 2025 annual meeting, and give the Ropes Lecture at the 2026 meeting.

    The Louis W. Sullivan, MD, Award recognizes a middle-career physician-scientist from a population underrepresented in medicine and science. The award honors Dr. Sullivan (born 1933), a hematologist, health care advocate, and policy leader — having served as US Secretary of Health and Human Services — and who was the first Black physician-scientist elected to the ASCI. The recipient of this award will receive a $10,000 honorarium, be recognized at the ASCI’s 2025 annual meeting, and give the Sullivan Lecture at the 2026 meeting.

    ASCI members who were elected in 2020 or more recently may be nominated. Additionally:

    • For the Ropes Award, only female members are eligible for nomination.
    • For the Sullivan Award, only UiMS members are eligible for nomination.

    The deadline for receipt of nominations is November 4, 2024, at 11:59 pm Eastern. Nominations will be screened to ensure they are complete and fit the award criteria. The ASCI’s Diversity, Equity, and Inclusion Committee will review nominations and submit recommendations to the ASCI Council for approval. We expect to notify nominees about the outcome by mid-December 2024.

    Nominators:

    • must be ASCI members; current members of the ASCI Council and Diversity, Equity, and Inclusion Committee are excluded; and
    • must provide a statement regarding the nominee (500-word limit).

    Nominees:

    • must fit the criteria noted above and may not be current members of the ASCI Council and/or Diversity, Equity, and Inclusion Committee;
    • may be nominated for only one ASCI award (for example, a nominee for the Ropes Award may not be nominated for the Sullivan Award, Korsmeyer Award, Harrington Prize, or Scharschmidt~Crawford Award);
    • must provide the following:
      • a personal statement (750-word limit) on their scientific achievements, with attention to relevant personal and career history (including a statement on diversity), mentoring experience, and service to the community;
      • a full curriculum vitae; and
      • 3 most-significant publications, each with a 50-word annotation, followed by the member’s role in the publication, the journal name and publication year, and the Pubmed ID noted as “PMID:12345”;
    • must complete the ASCI’s demographics survey; and
    • must provide information regarding their research domain(s).

    To start a nomination:

    • Access your member account
    • Go to the “Nominations” tab
    • In the section for the award of interest:
      • If you are the nominee, select the “I’m the nominee” option to start your part of the nomination (only you have access to this information); note that in the case of the Ropes Award, this option will not be available for male members.
      • If you are the nominator, select “I’m the nominator” option, then search for your nominee. Only nominees who were elected starting 2020 will appear in the results. Note: for the Ropes Award, you will only be able to select a nominee who is a woman; for the Sullivan Award, you may select anyone who is within the election-year window, but nominations will be screened (based on the information the nominee provides in the demographics survey) to ensure they fit the UiMS criterion.

    Definition of UiMS

    The ASCI defines underrepresented in medicine in science as follows: Underrepresented in medicine and science (UiMS) refers to populations that are underrepresented relative to their numbers in the general US population. This includes, but is not necessarily limited to, physician-scientists who identify in the following racial and/or ethnic groups: Black/African American, Hispanic or Latin American, Native American/American Indian or Alaska Native, and Native Hawaiian and other Pacific Islander; individuals with disabilities: physical or mental impairment that substantially limits one or more major life activities; and those with an educationally or financially disadvantaged background.

    Nominations open for the 2025 ASCI / Stanley J. Korsmeyer Award

    Posted on by John Hawley

    Nominations for the ASCI’s 2025 ASCI / Stanley J. Korsmeyer Award are now open.

    This prestigious recognition, first called the ASCI Award, was renamed in 2006 in honor of Dr. Korsmeyer, the first recipient of the Award in 1998, who passed away in 2005. The Award recognizes individuals for their advancement of knowledge in a specific field and for mentoring future generations of life science researchers. Information on all past honorees is available here.

    The Awardee delivers the Korsmeyer Award Lecture at the 2025 AAP/ASCI/APSA Joint Meeting and receives an unrestricted $20,000 honorarium.

    Current Active and International ASCI members are eligible for nomination. Prior nominees who remain eligible may be re-nominated. However, current ASCI Council members and prior Award recipients may not be nominated.

    The deadline for receipt of nominations is October 31, 2024, at 11:59 pm Eastern (extended from October 23). Nominations will be screened to ensure they are complete and fit the nomination criteria. The Council reviews nominations, with the outcome of review expected toward the end of November 2024.

    Nominators:

    • may be any ASCI member in good standing, including members of the Council;
    • must provide a statement (250-word limit) regarding the nominee; and
    • must comment regarding other investigators who have significantly contributed to the discoveries related to the nomination.

    Nominees:

    • must currently be an Active or International member (age 55 or younger);
    • must provide a biosketch, full curriculum vitae, and a trainee table;
    • must identify a former mentee to provide a statement of support (500-word limit);
    • must complete the ASCI’s demographic survey; and
    • must identify their research domain(s).

    To start a nomination:

    Nominations may be started by the nominator or the nominee:

    • Access your member account
    • Go to the “Activities / nominations” tab
    • Go to the section for “ASCI / Stanley J. Korsmeyer Award”

    For the nominator:

    • Select “I’m the nominator” option
    • Search for your nominee
    • Click on “Start nomination”
    • If the nominee has not already claimed her/his part of the nomination, click on “Send nominee information to access the nominee’s part of the nomination” to send the nominee an email to access and edit her/his aspect of the nomination (see above).
    • Supply the required information (see above)
    • Submit this aspect of the nomination

    For the nominee:

    • Select “I’m the nominee” option
    • Supply the required information (see above)
    • Submit this aspect of the nomination

    Nominations open for the 2025 ASCI / Scharschmidt~Crawford Distinguished Lectureship and Award

    Posted on by John Hawley

    Nominations for the ASCI’s 2025 Bruce F. Scharschmidt & Peggy S. Crawford Translational Medicine Distinguished Lectureship and Award are now open.

    The Award recognizes those who have made important contributions to the development of high-impact diagnostics or therapeutics for patients. The Awardee delivers the Scharschmidt~Crawford Distinguished Lectureship at the annual AAP/ASCI/APSA Joint Meeting and receives an unrestricted $20,000 honorarium. Drs. Scharschmidt and Crawford have pledged a very generous philanthropic gift to the ASCI to fully endow the Award, the first of which will be presented at the 2025 Joint Meeting, April 25-27.

    Any person with an MD or equivalent, regardless of ASCI membership, is eligible for nomination. However, current ASCI Council members may not be nominated.

    The deadline for receipt of nominations is October 31, 2024, at 11:59 pm Eastern (extended from October 23). Nominations will be screened to ensure they are complete and fit the nomination criteria. The Council reviews nominations, with the outcome of review expected in December 2024.

    Nominators:

    • may be any ASCI member in good standing, including members of the Council, and
    • must provide a statement (250-word limit) regarding the nominee.

    Nominees:

    • may be any person with an MD or equivalent, regardless of ASCI membership, but excluding members of the Council;
    • must be able to attend the 2025 Joint Meeting, April 25-27, in Chicago;
    • must provide a 500-word-limit description of their contributions to the development of high-impact diagnostics or therapeutics for patients;
    • must provide a full curriculum vitae;
    • must complete the ASCI’s demographic survey; and
    • must provide information regarding their research domain(s).

    To start a nomination:

    Nominations may be started by the nominator or the nominee:

    • Access your member account
    • Go to the “Activities / nominations” tab
    • Go to the section for “ASCI / Scharschmidt~Crawford Distinguished Lectureship and Award”

    For the nominator:

    • Select “I’m the nominator” option
    • Search for your nominee
    • Click on “Start nomination”
    • If the nominee has not already claimed her/his part of the nomination, click on “Send nominee information to access the nominee’s part of the nomination” to send the nominee an email to access and edit her/his aspect of the nomination (see above).
    • Supply the required information (see above)
    • Submit this aspect of the nomination

    For the nominee:

    … if the nominee is an ASCI member:

    • Select “I’m the nominee” option
    • Supply the required information (see above)
    • Submit this aspect of the nomination

    … if the nominee is not ASCI member, the nominee can email staff@the-asci.org to have a nomination set up by staff.